Menard Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4
Closed -$1.48K 158
2024
Q4
$1.48K Buy
+4
New +$1.67K ﹤0.01% 290

Other funds holding ELV

Menard Financial Group's ELV Position: Q1 2025 in Review

Menard Financial Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 4 shares — an estimated $1.48K sold.

Menard Financial Group first reported a position in ELV in Q4 2024 and held it in 1 quarter. The position peaked at $1.48K in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Menard Financial Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 4 Elevance Health shares in Q1 2025, an estimated $1.48K.
  • Menard Financial Group first reported a position in Elevance Health in Q4 2024 and held it in 1 quarter.
  • Menard Financial Group's Elevance Health position peaked at $1.48K in Q4 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.